Macrolide-resistant Streptococcus pneumoniae: clinical implications for the empiric treatment of community-acquired respiratory tract infections.
作者信息
Brunton Stephen, Iannini Paul
机构信息
Faculty Development, Cabarrus Family Medicine Residency, Charlotte, North Carolina, USA.
出版信息
MedGenMed. 2005 Dec 7;7(4):63.
Abstract
摘要
相似文献
1
2
Community-acquired upper respiratory tract infections and the role of third-generation oral cephalosporins.社区获得性上呼吸道感染与第三代口服头孢菌素的作用。
Expert Rev Anti Infect Ther. 2010 Jan;8(1):15-21. doi: 10.1586/eri.09.115.
3
Clinical impact of antibiotic resistance in respiratory tract infections.呼吸道感染中抗生素耐药性的临床影响。
Int J Antimicrob Agents. 2007 Feb;29 Suppl 1:S6-10. doi: 10.1016/S0924-8579(07)70004-3.
4
Novel cost-effective approaches to the treatment of community-acquired infections.
Ann Pharmacother. 1998 Jan;32(1):S27-30. doi: 10.1177/106002809803200107.
5
The in vivo-in vitro paradox in pneumococcal respiratory tract infections.
J Antimicrob Chemother. 2002 Mar;49(3):433-6. doi: 10.1093/jac/49.3.433.
6
Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin.由耐药肺炎球菌引起的社区获得性呼吸道感染：酮内酯类药物泰利霉素的临床和细菌学疗效
J Antimicrob Chemother. 2003 Apr;51(4):947-55. doi: 10.1093/jac/dkg153. Epub 2003 Mar 13.
7
Therapeutic implications of macrolide resistance in pneumococcal community-acquired lower respiratory tract infections.肺炎球菌社区获得性下呼吸道感染中大环内酯类耐药的治疗意义
Int J Clin Pract. 2004 Aug;58(8):769-76. doi: 10.1111/j.1368-5031.2004.00152.x.
8
Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program.社区获得性呼吸道感染及住院肺炎患者中肺炎链球菌和流感嗜血杆菌药敏性比较：哨兵抗菌监测计划五年结果
Diagn Microbiol Infect Dis. 2003 Aug;46(4):285-9. doi: 10.1016/s0732-8893(03)00087-7.
9
[beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].[β-内酰胺类抗生素治疗对青霉素耐药肺炎球菌引起的社区获得性呼吸道感染]
Pneumologie. 2002 Oct;56(10):605-9. doi: 10.1055/s-2002-34607.
10
Primary care challenges in the management of respiratory tract infections.呼吸道感染管理中的基层医疗挑战
JAAPA. 2006 Sep;Suppl:4-14; quiz 15-6.
本文引用的文献
1
Update on treatment guidelines for acute bacterial sinusitis.急性细菌性鼻窦炎治疗指南的更新
Int J Clin Pract. 2005 Feb;59(2):230-8. doi: 10.1111/j.1742-1241.2005.00378.x.
2
Predicting antimicrobial resistance in invasive pneumococcal infections.预测侵袭性肺炎球菌感染中的抗菌药物耐药性。
Clin Infect Dis. 2005 May 1;40(9):1288-97. doi: 10.1086/429242. Epub 2005 Mar 31.
3
Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14.葡萄牙侵袭性耐红霉素肺炎链球菌菌株的出现：14型的贡献及系统发育相关性
J Antimicrob Chemother. 2004 Dec;54(6):1035-9. doi: 10.1093/jac/dkh469. Epub 2004 Nov 5.
4
A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae.与耐大环内酯类肺炎链球菌相关的临床失败病例综述。
Int J Antimicrob Agents. 2004 Aug;24(2):95-104. doi: 10.1016/j.ijantimicag.2004.03.008.
5
Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.从呼吸道感染患者中分离出的肺炎链球菌菌株对大环内酯类药物的耐药性及耐药机制在美国的分布情况：2001 - 2002年美国肺炎链球菌耐药性监测研究（PROTEKT US）
J Antimicrob Chemother. 2004 Aug;54 Suppl 1:i17-22. doi: 10.1093/jac/dkh312.
6
Antimicrobial treatment guidelines for acute bacterial rhinosinusitis.急性细菌性鼻窦炎的抗菌治疗指南
Otolaryngol Head Neck Surg. 2004 Jan;130(1 Suppl):1-45. doi: 10.1016/j.otohns.2003.12.003.
7
Appropriate antibiotic use and why it is important: the challenges of bacterial resistance.合理使用抗生素及其重要性：细菌耐药性带来的挑战。
Pediatr Infect Dis J. 2003 Dec;22(12):1143-51. doi: 10.1097/01.inf.0000101851.57263.63.
8
Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.免疫功能正常的成年人社区获得性肺炎管理实践指南的更新
Clin Infect Dis. 2003 Dec 1;37(11):1405-33. doi: 10.1086/380488. Epub 2003 Nov 3.
9
Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolones.加替沙星、吉米沙星和莫西沙星：三种新型氟喹诺酮类药物的作用
Clin Infect Dis. 2003 Nov 1;37(9):1210-5. doi: 10.1086/378809. Epub 2003 Oct 2.
10
The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.1998 - 2000年亚历山大项目：社区获得性呼吸道感染分离病原体对常用抗菌药物的敏感性
J Antimicrob Chemother. 2003 Aug;52(2):229-46. doi: 10.1093/jac/dkg321. Epub 2003 Jul 15.
Zotero 插件